|
Re: Cynical Compensation
|
3
|
Resverlogix Corp.
|
Jul 21, 2023 10:52AM
|
|
xB3-001 partnership
|
3
|
BIOASIS TECHNOLOGIES INC
|
Dec 11, 2020 09:28AM
|
|
Re: The worse performing stock!
|
3
|
Resverlogix Corp.
|
Dec 08, 2020 05:31PM
|
|
Re: Just checked the chart again....seeing another wedge
|
3
|
Resverlogix Corp.
|
Apr 03, 2019 07:28PM
|
|
Re: Idea for Zenith
|
3
|
Zenith Epigenetics
|
Jul 14, 2021 11:17AM
|
|
Re: Zenith Shareholders
|
3
|
Zenith Epigenetics
|
Sep 01, 2021 02:25PM
|
|
Re: Flavoured HIV drug for children to be rolled out in Africa?
|
3
|
Resverlogix Corp.
|
Dec 02, 2020 01:11PM
|
|
RVX Level II
|
3
|
Resverlogix Corp.
|
Dec 11, 2020 09:42AM
|
|
Re: Saudi
|
3
|
Resverlogix Corp.
|
Jan 09, 2021 11:54AM
|
|
Additional Exempt Distribution- 2023-05-11
|
3
|
Zenith Epigenetics
|
Jun 02, 2023 08:38AM
|
|
Re: Lower LDL-C and Increased Type 2 Diabetes Risk
|
3
|
Resverlogix Corp.
|
Jun 04, 2020 07:28AM
|
|
Re: Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions
|
3
|
Resverlogix Corp.
|
Sep 28, 2022 04:41PM
|
|
Message Continuing on Clinical Trials Arena
|
3
|
Resverlogix Corp.
|
Jan 20, 2022 08:23AM
|
|
Re: RVXCF Short # drops 5.28% below 200k
|
3
|
Resverlogix Corp.
|
Mar 27, 2024 12:07PM
|
|
Re: CityNews cover
|
3
|
Resverlogix Corp.
|
Jan 31, 2022 01:01PM
|
|
Re: Report of exempt distribution
|
3
|
Resverlogix Corp.
|
Nov 10, 2020 09:22PM
|
|
Re: Level 2 Quotes this morning
|
3
|
Resverlogix Corp.
|
Jun 16, 2022 10:26AM
|
|
Re: Q4 2019 Events
|
3
|
Resverlogix Corp.
|
Oct 01, 2019 05:52PM
|
|
Re: Fair warning to everyone here....
|
3
|
Resverlogix Corp.
|
Jun 24, 2019 10:30PM
|
|
Re: Zenith-Oncology Pipeline
|
3
|
Zenith Epigenetics
|
Mar 18, 2021 05:10PM
|
